• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Israel·Healthcare·ILX.TA
Share

Ilex Medical Ltd Stocks

ILA 5091Last Updated 16.09.2026

Issuer Rating

4/7
Performance

Favourable

Risk

Considerable

Recommendation

Hold

Market Cap

ILA 1.85M

ILA 5091
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Ilex Medical Ltd. engages in medical diagnostics field. It operates through the following segments: Medical Laboratory Equipment and Diagnostics Materials, Medical Equipment, and Inhalation Devices. The Medical Laboratory Equipment and Diagnostics Materials segment deals with the marketing, distribution, and sale of laboratory medical equipment and diagnostics products, diagnostics systems, kits, and consumables for the examination of medical laboratories in hospitals. The Medical Equipment segment handles importation, marketing, and distribution of medical equipment and devices in Israel. The Inhalation Devices segment includes development, manufacture, and marketing of mobile inhalation devices. The company was founded by Moshe Ben Shaul in 1977 and is headquartered in Petach Tikva, Israel.

Company Valuation

Greatly undervalued
7/7

From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks. In particular, the stock is reasonably priced on P/E, 'c

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

17.09.2026 20:43

Revolut Is Aiming for a Dual Listing in New York and London — Storonsky

17.09.2026 19:55

"They're playing with our lives": What is known about the mathematician who called for a slowdown in the AI race

17.09.2026 19:13

Nebius shares rose 11% following a price increase for AI chips. What might this indicate?

17.09.2026 18:41

The Nasdaq jumped more than 1% on the back of falling oil prices and bond yields

17.09.2026 18:11

Is the Rally Stalling? How a Fed Rate Hike Could Affect the Markets

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026